0001209191-19-046913.txt : 20190820
0001209191-19-046913.hdr.sgml : 20190820
20190820202757
ACCESSION NUMBER: 0001209191-19-046913
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190816
FILED AS OF DATE: 20190820
DATE AS OF CHANGE: 20190820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foresite Capital Fund IV, L.P.
CENTRAL INDEX KEY: 0001704131
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 191041104
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET, SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET, SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tananbaum James B.
CENTRAL INDEX KEY: 0001581754
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 191041105
MAIL ADDRESS:
STREET 1: 3052 PACIFIC AVENUE
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foresite Capital Management II, LLC
CENTRAL INDEX KEY: 0001594912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 191041106
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foresite Capital Fund II, L.P.
CENTRAL INDEX KEY: 0001594914
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 191041107
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foresite Capital Management III, LLC
CENTRAL INDEX KEY: 0001645157
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 191041108
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foresite Capital Fund III, L.P.
CENTRAL INDEX KEY: 0001645158
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 191041109
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foresite Capital Management IV, LLC
CENTRAL INDEX KEY: 0001704132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 191041110
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET, SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET, SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 237-5300
MAIL ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-16
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001594912
Foresite Capital Management II, LLC
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA
94111
0
0
1
0
0001594914
Foresite Capital Fund II, L.P.
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA
94111
0
0
1
0
0001645157
Foresite Capital Management III, LLC
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA
94111
0
0
1
0
0001645158
Foresite Capital Fund III, L.P.
600 MONTGOMERY STREEET
SUITE 4500
SAN FRANCISCO
CA
94111
0
0
1
0
0001704132
Foresite Capital Management IV, LLC
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA
94111
0
0
1
0
0001704131
Foresite Capital Fund IV, L.P.
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA
94111
0
0
1
0
0001581754
Tananbaum James B.
600 MONTGOMERY STREET
SUITE 4500
SAN FRANCISCO
CA
94111
0
0
1
0
Common Stock
2019-08-16
4
P
0
100000
24.23
A
2150477
I
See Footnote
Common Stock
2019-08-19
4
P
0
3847
23.34
A
2154324
I
See Footnote
Common Stock
2019-08-20
4
P
0
50000
23.21
A
2204324
I
See Footnote
This transaction was executed in multiple trades at prices ranging from $23.73 to $24.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares are owned directly by Foresite Capital Fund III, L.P. ("FCF III"). Foresite Capital Management III, LLC ("FCM III"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
This transaction was executed in multiple trades at prices ranging from $23.22 to $23.42. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $22.82 to $23.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
FORESITE CAPITAL MANAGEMENT II, LLC, By: /s/ James B. Tananbaum, Managing Member
2019-08-20
FORESITE CAPITAL FUND II, L.P., By: Foresite Capital Management II, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member
2019-08-20
FORESITE CAPITAL MANAGEMENT III, LLC, By: /s/ James B. Tananbaum, Managing Member
2019-08-20
FORESITE CAPITAL FUND III, L.P., By: Foresite Capital Management III, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member
2019-08-20
FORESITE CAPITAL MANAGEMENT IV, LLC, By: /s/ James B. Tananbaum, Managing Member
2019-08-20
FORESITE CAPITAL FUND IV, L.P., By: Foresite Capital Management IV, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member
2019-08-20
/s/ James B. Tananbaum
2019-08-20